# Monotherapy With Rapamycin in Long-standing Type 1 Diabetes

> **NCT02803892** · PHASE2 · COMPLETED · sponsor: **Piemonti Lorenzo** · enrollment: 55 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** rapamycin
- **DRUG:** Vildagliptin
- **DRUG:** Placebo 1
- **DRUG:** Placebo 2

## Key facts

- **NCT ID:** NCT02803892
- **Lead sponsor:** Piemonti Lorenzo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02803892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02803892, "Monotherapy With Rapamycin in Long-standing Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02803892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*